Stem Point Capital LP Clear Point Neuro, Inc. Transaction History
Stem Point Capital LP
- $499 Billion
- Q3 2025
A detailed history of Stem Point Capital LP transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 16,651 shares of CLPT stock, worth $257,923. This represents 0.07% of its overall portfolio holdings.
Number of Shares
16,651Holding current value
$257,923% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
113Shares Held
8.38MCall Options Held
437KPut Options Held
199K-
Vanguard Group Inc Valley Forge, PA1.5MShares$23.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA656KShares$10.2 Million0.0% of portfolio
-
State Street Corp Boston, MA483KShares$7.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.68 Million0.0% of portfolio
-
Ubs Group Ag361KShares$5.59 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $379M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...